Abstract

BackgroundUganda has one of the highest total fertility rates (TFR) worldwide. We compared the effects of antiretroviral (ARV) prophylaxis for the prevention of mother-to-child HIV transmission (PMTCT) to that of existing family planning (FP) use and estimated the burden of pediatric HIV disease due to unwanted fertility.Methodology/Principal FindingsUsing the demographic software Spectrum, a baseline mathematical projection to estimate the current pediatric HIV burden in Uganda was compared to three hypothetical projections: 1) without ARV-PMTCT (to estimate the effect of ARV-PMTCT), 2) without contraception (effect of existing FP use), 3) without unwanted fertility (effect of unmet FP needs). Key input parameters included HIV prevalence, ARV-PMTCT uptake, MTCT probabilities, and TFR. We estimate that in 2007, an estimated 25,000 vertical infections and 17,000 pediatric AIDS deaths occurred (baseline projection). Existing ARV-PMTCT likely averted 8.1% of infections and 8.5% of deaths. FP use likely averted 19.7% of infections and 13.1% of deaths. Unwanted fertility accounted for 21.3% of infections and 13.4% of deaths. During 2008–2012, an estimated 131,000 vertical infections and 71,000 pediatric AIDS deaths will occur. The projected scale up of ARV-PMTCT (from 39%–57%) may avert 18.1% of infections and 24.5% of deaths. Projected FP use may avert 21.6% of infections and 18.5% of deaths. Unwanted fertility will account for 24.5% of infections and 19.8% of deaths.ConclusionsExisting FP use contributes as much or more than ARV-PMTCT in mitigating pediatric HIV in Uganda. Expanding FP services can substantially contribute towards PMTCT.

Highlights

  • Mother-to-child HIV transmission (MTCT) is the second largest mode of HIV transmission worldwide, accounting for some 370,000 infections in 2007 [1]

  • Expanding family planning (FP) services can substantially contribute towards prevention of mother-to-child HIV transmission (PMTCT)

  • 25,000 vertical HIV infections occurred in the presence of the existing FP use and ARV-PMTCT program

Read more

Summary

Introduction

Mother-to-child HIV transmission (MTCT) is the second largest mode of HIV transmission worldwide, accounting for some 370,000 infections in 2007 [1]. In many countries PMTCT programs focus on antenatal HIV testing, provision of ARV prophylaxis to HIV-infected women and their newborns, and counseling on safer infant feeding practices. These three components constitute just one of four pillars for PMTCT; the remaining being primary HIV prevention in women of child-bearing age, family planning (FP) for the prevention of unwanted pregnancies, as well as care and treatment for HIV-infected women [3] and their HIV-affected children [4]. We compared the effects of antiretroviral (ARV) prophylaxis for the prevention of mother-to-child HIV transmission (PMTCT) to that of existing family planning (FP) use and estimated the burden of pediatric HIV disease due to unwanted fertility

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call